Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06649240Not ApplicableRecruiting
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
Cardiovascular DiseasesCholesterol, LDLIschemic Stroke+2 more
PrincipalinvestigatorStart date: 2024-10-04
NCT05995600Phase 4Active Not Recruiting
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
Antiphospholipid SyndromeCardiovascular DiseasesCerebrovascular Disease+3 more
PrincipalinvestigatorStart date: 2024-02-20

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06649240Not ApplicablePrincipalInvestigator

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

Cardiovascular DiseasesCholesterol, LDLIschemic Stroke+2 more
Recruiting
NCT05995600Phase 4PrincipalInvestigator

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

Antiphospholipid SyndromeCardiovascular DiseasesCerebrovascular Disease+3 more
Active Not Recruiting

All 2 trials loaded